---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-062116"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2024-05-20T23:59:59+00:00"
generated_at: "2026-06-01T12:15:43.725553+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics sets 2024 annual meeting for August 15; stockholder proposals due May 30

## Summary
- Annual meeting to be held virtually on August 15, 2024 at 9:00 a.m. Eastern Time.
- Record date for stockholders entitled to vote is June 25, 2024.
- Stockholder proposals and director nominations must be received by May 30, 2024 at 5:00 p.m. ET.

## SEC filing metadata
- accession: 0000950170-24-062116
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2024-05-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.08, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000095017024062116/0000950170-24-062116-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000095017024062116/pstv-20240516.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-062116
- JSON: https://secwatch.observer/filing/0000950170-24-062116.json
- Plain text: https://secwatch.observer/filing/0000950170-24-062116.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.